Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 2, 2015, Pages 230-235

  Bakker, S F ^a   Tushuizen, M E ^a   Gozutok E ^b   Ciftci A ^b   Gelderman, K A ^a   Mulder, C J ^a   Simsek, S ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Northwest Clinics   (Netherlands)

Author keywords

Advanced glycation end products; AGE; Autofluorescence; Coeliac disease; Gluten free diet; Soluble receptor AGE; Type 1 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; SRAGE PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOFLUORESCENCE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; UNIVARIATE ANALYSIS; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FOLLOW UP; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; SKIN; STATISTICAL MODEL;

ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELIAC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SKIN;

EID: 84922031843     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.10.009     Document Type: Article

References (30)

1. Chilelli N.C., Burlina S., Lapolla A. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Nutr Metab Cardiovasc Dis 2013, 23:913-919.
2. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009, 52:2251-2263.
3. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997, 94:6474-6479.
4. Holmes G.K. Coeliac disease and type 1 diabetes mellitus - the case for screening. Diabet Med 2001, 18:169-177.
5. Abadie V., Sollid L.M., Barreiro L.B., Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011, 29:493-525.
6. Malalasekera V., Cameron F., Grixti E., Thomas M.C. Potential reno-protective effects of a gluten-free diet in type 1 diabetes. Diabetologia 2009, 52:798-800.
7. Bakker S.F., Tushuizen M.E., von Blomberg M.E., Mulder C.J., Simsek S. Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications. Acta Diabetol 2013, 50:319-324.
8. Leeds J.S., Hopper A.D., Hadjivassiliou M., Tesfaye S., Sanders D.S. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011, 34:2158-2163.
9. Leeds J.S., Hopper A.D., Hadjivassiliou M., Tesfaye S., Sanders D.S. Potential coeliac disease in type 1 diabetes mellitus: does a positive antibody lead to increased complications?. Nutr Metab Cardiovasc Dis 2014, 24:378-383.
10. Mollazadegan K., Kugelberg M., Montgomery S.M., Sanders D.S., Ludvigsson J., Ludvigsson J.F. A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 2013, 36:316-321.
11. Picarelli A., Di T.M., Sabbatella L., Mercuri V., Pietrobono D., Bassotti G., et al. Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol 2013, 50:497-503.
12. Pitocco D., Giubilato S., Martini F., Zaccardi F., Pazzano V., Manto A., et al. Combined atherogenic effects of celiac disease and type 1 diabetes mellitus. Atherosclerosis 2011, 217:531-535.
13. Husby S., Koletzko S., Korponay-Szabo I.R., Mearin M.L., Phillips A., Shamir R., et al. European Society for Pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54:136-160.
14. Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl. 1):S11-S63.
15. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
16. Hogen Esch C.E., Csizmadia G.D., van Hoogstraten I.M., Schreurs M.W., Mearin M.L., von Blomberg B.M. Childhood coeliac disease: towards an improved serological mass screening strategy. Aliment Pharmacol Ther 2010, 31:760-766.
17. Meerwaldt R., Links T., Graaff R., Thorpe S.R., Baynes J.W., Hartog J., et al. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005, 1043:290-298.
18. Koetsier M., Lutgers H.L., de J.C., Links T.P., Smit A.J., Graaff R. Reference values of skin autofluorescence. Diabetes Technol Ther 2010, 12:399-403.
19. Meerwaldt R., Lutgers H.L., Links T.P., Graaff R., Baynes J.W., Gans R.O., et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007, 30:107-112.
20. Pham-Short A., Donaghue C., Ambler G., Chan K., Hing S., Cusumano J., et al. Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes. Diabet Med 2014, 31:208-212.
21. Piarulli F., Sartore G., Lapolla A. Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. Acta Diabetol 2013, 50:101-110.
22. Pugliese G. Do advanced glycation end products contribute to the development of long-term diabetic complications?. Nutr Metab Cardiovasc Dis 2008, 18:457-460.
23. Nin J.W., Ferreira I., Schalkwijk C.G., Prins M.H., Chaturvedi N., Fuller J.H., et al. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study. Diabetologia 2009, 52:705-714.
24. Thomas M.C., Soderlund J., Lehto M., Makinen V.P., Moran J.L., Cooper M.E., et al. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 2011, 54:2669-2677.
25. Gopee E., van den Oever E.L., Cameron F., Thomas M.C. Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes. Pediatr Diabetes 2013, 14:455-458.
26. Araszkiewicz A., Naskret D., Niedzwiecki P., Samborski P., Wierusz-Wysocka B., Zozulinska-Ziolkiewicz D. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes. Diabetes Technol Ther 2011, 13:837-842.
27. Meerwaldt R., Links T.P., Graaff R., Hoogenberg K., Lefrandt J.D., Baynes J.W., et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005, 48:1637-1644.
28. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002, 99:15596-15601.
29. Stirban A., Nandrean S., Negrean M., Koschinsky T., Tschoepe D. Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther 2008, 10:200-205.
30. Meerwaldt R., Graaff R., Oomen P.H., Links T.P., Jager J.J., Alderson N.L., et al. Simple non-invasive assessment of advanced glycation end product accumulation. Diabetologia 2004, 47:1324-1330.